Aquinox Pulls In $18M In Venture Funds As COPD Drug Moves Forward
This article was originally published in The Pink Sheet Daily
Executive Summary
The Canadian company will use the funds from its Series C financing to advance its lead drug candidate through Phase II testing in two indications, including COPD.